Take Action

January 18, 2024

We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Throughout the year, you will have the opportunity to participate in campaigns that support endocrinology research, care, professionals, and patients. Contact us to get more involved: [email protected].

Taking action by sending messages to your Congressional delegation makes a difference, and our online campaigns make it easy to do. Don't take it from us, hear from Rosa DeLauro, Ranking Member of the House Appropriations Committee, why your voice matters.


NEW CAMPAIGN: URGE CONGRESS TO FUND NIH AND SPECIAL DIABETES PROGRAM

Congress has yet to complete the appropriations process for Fiscal Year (FY) 2024, and the clock is ticking on two issues important to endocrinology: funding for the National Institutes of Health (NIH) and funding for the Special Diabetes Program (SDP). We need ALL U.S. members of the Endocrine Society to join our campaign to urge Congress to complete the appropriations process for FY 2024 and protect NIH funding, extend SDP, and provide a funding increase for NIH in FY 2025. All Members of Congress need to hear these messages today. 


URGE CONGRESS TO PASS THE TREAT AND REDUCE OBESITY ACT (TROA)

Obesity has damaged our nation’s health, and its prevalence is increasing: over 42% of US adults and over 19% of children are estimated to have obesity. The Endocrine Society is urging the U.S. House of Representatives and Senate to pass the Treat and Reduce Obesity Act (TROA). This legislation would allow coverage of anti-obesity medications (AOMs) currently prohibited in the Medicare statute and expand access to intensive behavioral therapy (IBT) for obesity. It is critical that your Senators and Representatives hear from you on the importance of passing this legislation.


URGE CONGRESS TO MAKE INSULIN AFFORDABLE FOR PEOPLE ON PRIVATE INSURANCE 

The Endocrine Society is urging the Senate to pass the bipartisan Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act. Last year, President Biden signed the Inflation Reduction Act into law, which capped insulin costs for Medicare beneficiaries. However, insulin remains unaffordable for people with private insurance. Join our campaign today to remind your Senators that addressing insulin affordability for people with private insurance is a top priority.

Last Updated:
Take Action

Urge Congress to Protect NIH From Cuts in FY24

Congress is in the process of determining funding for the National Institutes of Health (NIH) in fiscal year (FY) 2024.  This will affect all researchers who receive grant funding from NIH. To protect NIH from severe cuts, it is critical that your Representative and Senators hear from you about this issue.

Congress is in the process of determining funding for the National Institutes of Health (NIH) in fiscal year (FY) 2024.  This will affect all researchers who receive grant funding from NIH. To protect NIH from severe cuts, it is critical that your Representative and Senators hear from you about this issue.

Endocrine Disrupting Chemicals

EDCs EU Newsletter

Read our newsletters covering the latest science-based information on endocrine-disrupting chemicals (EDCs) for policymakers in the European Union.
Endocrine Disrupting Chemicals

EDCs EU Newsletter

Read our newsletters covering the latest science-based information on endocrine-disrupting chemicals (EDCs) for policymakers in the European Union.

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.